Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Library Archives
Volume 12, 2008 Archive

Six issues from 2008 in one convenient archive.

  • Full-color, full-text PDF files of articles and formulations from the Journal.
  • Print or save articles for your research, marketing, and educational needs.
  • Log-in to your account for keyword or topical search and download.
  • Purchased items appear with download icon in contents and search results.

Only $30000


(Select Format)
Instant Online Access

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Issue/Volume Title
January/February 2008
Vol. 12 No. 1
Compounding for Hospice and Cancer Patients
March/April 2008
Vol. 12 No. 2
Compounding Around the World
May/June 2008
Vol. 12 No. 3
Pain Management
July/August 2008
Vol. 12 No. 4
Hormone Replacement Therapy
September/October 2008
Vol. 12 No. 5
Veterinary Compounding
November/December 2008
Vol. 12 No. 6
Arthritis and Immunological Diseases

Volume 12, 2008 Articles
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
PreScription: Year Number 12…And Still Much Work to Do
Allen Loyd V Jr
Jan/Feb 2008
Pg. 4

Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration
Dib Jean G
, Abdulmohsin Saud
Jan/Feb 2008
Pg. 8-14

Cancer-Related Terminology: Glossaries for Compounding Pharmacists and Their Clients
Williams LaVonn A
Jan/Feb 2008
Pg. 16-27

Hospice and Compounding Pharmacy: Once Inseperable
Williams LaVonn A
Jan/Feb 2008
Pg. 28-37

Disposing of Expired Drugs and Chemicals: New Options for Compounders
Vail Jane
Jan/Feb 2008
Pg. 38-47

View Sample
Websites: Keeping Current in 2008
Storey Patricia L
Jan/Feb 2008
Pg. 48-49

Quality-Control Analytical Methods: Stability Versus Potency Testing: The Madness is in the Method
Kupiec Thomas C
, Skinner Rodney, Lanier Lance
Jan/Feb 2008
Pg. 50-53

Calculations: Compounding for Cancer Patients
Stockton Shelly J
Jan/Feb 2008
Pg. 62

Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996
Allen Loyd V Jr
Jan/Feb 2008
Pg. 63

Cyclosporine Topical Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 64

Diclofenac Sodium 1% Soft-Patch Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 65

Diclofenac Sodium 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 66

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations
Allen Loyd V Jr
, Okeke Claudia C
Jan/Feb 2008
Pg. 54-60

Diltiazem 5% in Lipoderm, Veterinary
Allen Loyd V Jr
Jan/Feb 2008
Pg. 67

Emetine Hydrochloride 30-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2008
Pg. 68

Flosulide 10-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2008
Pg. 69

Pentoxifylline 20-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2008
Pg. 70

Piroxicam 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 71

Piroxicam 1% Soft-Patch Topical Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 72

Trimethoprim 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2008
Pg. 73

Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists
Huffman DC
, Holmes Erin R
Jan/Feb 2008
Pg. 74-82

Room Temperature Stability of Injectable Succinylcholine Dichloride
Roy Julie J
, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice
Jan/Feb 2008
Pg. 83-85

2007 Reviewers
Jan/Feb 2008
Pg. 86

PostScription: Consumer Options for Disposal of Unused Medications
Vail Jane
Jan/Feb 2008
Pg. 87

PreScription: Compounding Around the World
Allen Loyd V Jr
Mar/Apr 2008
Pg. 92

Current Compounding Practices in Europe
Carvalho Maria
, Tuleu Catherine, Taylor Kevin MG
Mar/Apr 2008
Pg. 94-99

Compounding Around the World
Vail Jane
Mar/Apr 2008
Pg. 102-115

Establishing a Quality-Assurance Program for Hospital Compounding
McElhiney Linda F
Mar/Apr 2008
Pg. 116-120

Hormone Therapy: It's Time for a Second Opinion
Collins Joseph J
, Ahlgrimm Maria
Mar/Apr 2008
Pg. 122-127

Newsletters: An Essential Marketing Tool
Storey Patricia L
Mar/Apr 2008
Pg. 128-129

Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm!
Odegard Russell D
Mar/Apr 2008
Pg. 130-135

Calculations
Stockton Shelly J
Mar/Apr 2008
Pg. 145

Acyclovir 5% Topical Ointment
Allen Loyd V Jr
Mar/Apr 2008
Pg. 146

Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Trusley Craig
, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008
Pg. 156-160

Chemical Stability of Tramadol Hydrochloride Injection
Gupta Vishnu D
Mar/Apr 2008
Pg. 161-162

Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting
de Oliveira Ferreira Anderson
, Holandino Carla
Mar/Apr 2008
Pg. 163-169

PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care
Murry Tom
Mar/Apr 2008
Pg. 174-175

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797>
Allen Loyd V Jr
, Okeke Claudia C
Mar/Apr 2008
Pg. 136-144

Alum 6.5% Topical Cream
Allen Loyd V Jr
Mar/Apr 2008
Pg. 147

Aminacrine Hydrochloride 0.1% Cream
Allen Loyd V Jr
Mar/Apr 2008
Pg. 148

Butesin Picrate 1% ointment
Allen Loyd V Jr
Mar/Apr 2008
Pg. 149

Carbamazepine Topical Preparations
Allen Loyd V Jr
Mar/Apr 2008
Pg. 150

Chlorhexidine Gel
Allen Loyd V Jr
Mar/Apr 2008
Pg. 151

EDTA 1% Cream
Allen Loyd V Jr
Mar/Apr 2008
Pg. 152

Erythromycin 1% and Neomycin Sulfate Ointment
Allen Loyd V Jr
Mar/Apr 2008
Pg. 153

Heparin Gel-Cream
Allen Loyd V Jr
Mar/Apr 2008
Pg. 154

Hydrogen Peroxide 8% Cream
Allen Loyd V Jr
Mar/Apr 2008
Pg. 155

Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Kupiec Thomas C
, Ben Michel, Trusley Craig, Trissel Lawrence A
Mar/Apr 2008
Pg. 170-173

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use
Allen Loyd V Jr
, Okeke Claudia C
May/Jun 2008
Pg. 252-257

Calculations
Stockton Shelly J
May/Jun 2008
Pg. 258

Standard Operating Procedure: Dealing with Patients Experiencing Pain: Presenting without a Prescription
Allen Loyd V Jr
May/Jun 2008
Pg. 259

African Scalp Lotion
Allen Loyd V Jr
May/Jun 2008
Pg. 260

Benzyl Benzoate Lotion
Allen Loyd V Jr
May/Jun 2008
Pg. 261

Calcium Gluconate 2.5% Topical Gel
Allen Loyd V Jr
May/Jun 2008
Pg. 262

Lubricating Gel
Allen Loyd V Jr
May/Jun 2008
Pg. 263

Meloxicam 0.3% Topical Gel
Allen Loyd V Jr
May/Jun 2008
Pg. 264

Miconazole Nitrate 2%, Deoxy-D-Glucose 0.2%, and Hydrocortisone 0.4% Lip Balm
Allen Loyd V Jr
May/Jun 2008
Pg. 265

Potassium Nitrate/Benzocaine/Tetracaine Dental Gel
Allen Loyd V Jr
May/Jun 2008
Pg. 266

Promethazine Hydrochloride 2.5-mg/mL Rectal Solution
Allen Loyd V Jr
May/Jun 2008
Pg. 267

Tolnaftate 1% Antifungal Microemulsion
Allen Loyd V Jr
May/Jun 2008
Pg. 268

Valsartan 4-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2008
Pg. 269

Chemical Stability of Naltrexone Hydrochloride Injection
Gupta Vishnu D
May/Jun 2008
Pg. 274-275

PostScription: A Contemporary Perspective on Compounding Education
Maine Lucinda L
May/Jun 2008
Pg. 279

Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards
Kastango Eric S
May/Jun 2008
Pg. 216-229

Communication with Pharmacy Technicians: How to Reduce Stress and Improve Pharmacy Operations
Fyke Jeremy P
, Hoffman Mary F
May/Jun 2008
Pg. 230-233

Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 3: Developing a Program of Quality Assurance and Continuous Quality Improvement
Cabaleiro Joe
May/Jun 2008
Pg. 234-236

PreScription: Pain!
Allen Loyd V Jr
May/Jun 2008
Pg. 180

Topical Treatment of Neuropathic Pain
Vadaurri Vince
May/Jun 2008
Pg. 182-190

Compounded Local Anesthetics to Minimize Pain from Medical Procedures
McElhiney Linda F
May/Jun 2008
Pg. 192-197

Dilution and Compounding of Ziconotide for Intrathecal Administration
Buchta Tony
, Fakata Keri, Stuart William
May/Jun 2008
Pg. 200-207

Pharmacy Compounding at the University of Connecticut: Secundum Artem et Scientia
Scagliarini Meghan
, Bogner Robin H
May/Jun 2008
Pg. 208-212

Developing and Implementing a Clinical Pharmacy Rotation in a Community Compounding Pharmacy
Walkup Kenny R
May/Jun 2008
Pg. 213-215

Litigating the Legality of Compounding: The Medical Center Pharmacy Case
Gibbs Jeffrey N
May/Jun 2008
Pg. 238-241

Developing a Niche Marketing Strategy
Storey Patricia L
May/Jun 2008
Pg. 242-243

Web 2.0 and Health 2.0: Are You In?
Felkey Bill G
May/Jun 2008
Pg. 244-246

A Process Verification Model for Quality Assurance in a Compounding Pharmacy
Zolner William J
May/Jun 2008
Pg. 247-251

Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model
Bassani August S
, Banov Daniel, Lehman Paul A
May/Jun 2008
Pg. 270-273

Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration
Chan Pak
, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2008
Pg. 276-278

PreScription: First Estriol, Then What?
Allen Loyd V Jr
Jul/Aug 2008
Pg. 284

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating
Allen Loyd V Jr
, Okeke Claudia C
Jul/Aug 2008
Pg. 344-353

Zirconium Oxide Lotion
Allen Loyd V Jr
Jul/Aug 2008
Pg. 364

Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada
Prot-Labarthe Sonia
, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
Jul/Aug 2008
Pg. 365-367

Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms
Gupta Vishnu D
Jul/Aug 2008
Pg. 372-374

PostScription: It Is Not Just What You Say…But How You Say It!
Reed-Kane Dana
Jul/Aug 2008
Pg. 375

Estriol: Women's Choice vs. A Manufacturer's Greed
Goodrum Jennifer
Jul/Aug 2008
Pg. 286-292

Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Jul/Aug 2008
Pg. 295-304

The Magic of Magnesium
Boomsma Diane
Jul/Aug 2008
Pg. 306-309

Progesterone and Traumatic Brain Injury: A Review of Literature
Williams LaVonn A
, Mead Jay H
Jul/Aug 2008
Pg. 310-315

Beyond-Use Dating, Labeling, Delivery, and Storage of Compounded and Repackaged Mediations in a Hospital or Institutional Setting
McElhiney Linda F
Jul/Aug 2008
Pg. 316-320

Microbial Air-Sampling Equipment, Part 2: Experiences of Compounding Pharmacists
Mixon Bill
, Cabaleiro Joe, Latta Kenneth S, Vail Jane
Jul/Aug 2008
Pg. 321-327

Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature
Fyke Jeremy P
, Yale Robert N, Corbett Corinne, Litera Natalie
Jul/Aug 2008
Pg. 329-333

Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization
Westrick Salisa C
, Felkey Bill G
Jul/Aug 2008
Pg. 334-337

Marketing for Your Community
Storey Patricia L
Jul/Aug 2008
Pg. 338-339

Quality-Control Analytical Methods: Homogeneity of Dosing Forms
Kupiec Thomas C
, Vu Nicole, Branscum David
Jul/Aug 2008
Pg. 340-343

Calculations
Stockton Shelly J
Jul/Aug 2008
Pg. 354

Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder
Allen Loyd V Jr
Jul/Aug 2008
Pg. 355

Silicone Cream
Allen Loyd V Jr
Jul/Aug 2008
Pg. 356

Sodium Chloride 0.9% Ointment
Allen Loyd V Jr
Jul/Aug 2008
Pg. 357

Squalene 0.2% Cream
Allen Loyd V Jr
Jul/Aug 2008
Pg. 358

Sucralfate and Hyaluronic Acid Ointment
Allen Loyd V Jr
Jul/Aug 2008
Pg. 359

Tretinoin and (-)Alpha-Bisabolol Gel
Allen Loyd V Jr
Jul/Aug 2008
Pg. 360

Tretinoin and Dexpanthenol Gel
Allen Loyd V Jr
Jul/Aug 2008
Pg. 361

Ultrasonic Adhesive Gel
Allen Loyd V Jr
Jul/Aug 2008
Pg. 362

Vitamin A Suppository
Allen Loyd V Jr
Jul/Aug 2008
Pg. 363

Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration
Ben Michel
, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 2008
Pg. 368-371

PreScription: Compounding Around the World
Allen Loyd V Jr
Sep/Oct 2008
Pg. 382

Canine Public Servants: Caring for Drug Detection Dogs
Davidson Gigi S
Sep/Oct 2008
Pg. 384-390

Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William
, Helms Scott R
Sep/Oct 2008
Pg. 392-397

Veterinary Compounding for Myasthenia Gravis
Davidson Gigi S
Sep/Oct 2008
Pg. 398-401

Equine Anesthesia: Triple Drip
Davidson Gigi S
Sep/Oct 2008
Pg. 402-404

Publication Expansion of United States Pharmacopeial Convention's Veterinary Standards and Clinical Information
Neal Amy S
, DeVeau Ian, Schnatz Rick G
Sep/Oct 2008
Pg. 405-409

Golden Ticket to the United States Pharmacopeial Convention's Veterinary Internship
Kirk Loren Madden
Sep/Oct 2008
Pg. 410-413

Calculations
Stockton Shelly J
Sep/Oct 2008
Pg. 444-445

Aceclofenac 1.5% Gel-Cream
Allen Loyd V Jr
Sep/Oct 2008
Pg. 446

Testing the Long-Term Stability of Vancomycin Ophthalmic Solution
McLellan Christine
, Ngo Van, Pasedis Sophia, Dohlman Claes H
Sep/Oct 2008
Pg. 456-459

Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration
Ben Michel
, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
Sep/Oct 2008
Pg. 460-462

Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration
Shields David E
, Aclan Jennifer, Szatkowski Aaron
Sep/Oct 2008
Pg. 463-466

Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers
Fyke Jeremy P
, Yale Robert N, Corbett Corinne, Litera Natalie
Sep/Oct 2008
Pg. 414-418

Insurance for the Compounding Pharmacy Business, Part 1: Who Is Covered?
Baker Kenneth R
Sep/Oct 2008
Pg. 420-424

Excipient Choices for Special Populations
Nagel-Edwards Karen M
, Ko James Y
Sep/Oct 2008
Pg. 426-430

Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 4L Tips for "Last Minute" Preparations
Cabaleiro Joe
Sep/Oct 2008
Pg. 432-433

Technology for the Patient-Centric Pharmacy
Felkey Bill G
Sep/Oct 2008
Pg. 434-437

Acetaminophen 10-mg/mL Rectal Solution
Allen Loyd V Jr
Sep/Oct 2008
Pg. 447

Carnitine 400-mg/mL and Coenzyme Q10 10-mg/mL Solution
Allen Loyd V Jr
Sep/Oct 2008
Pg. 448

Marketing: Taking Your Show on the Road
Storey Patricia L
Sep/Oct 2008
Pg. 438-439

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations
Allen Loyd V Jr
, Okeke Claudia C
Sep/Oct 2008
Pg. 440-443

Dichlorobenzyl Alcohol Tooth Gel
Allen Loyd V Jr
Sep/Oct 2008
Pg. 449

Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
Sep/Oct 2008
Pg. 450

Flurandrenolide Topical Film
Allen Loyd V Jr
Sep/Oct 2008
Pg. 451

Ketoprofen 20% Topical Solution
Allen Loyd V Jr
Sep/Oct 2008
Pg. 452

Lidocaine Adhesive System Gel
Allen Loyd V Jr
Sep/Oct 2008
Pg. 453

Piroxicam 5% and Dexpanthenol 5% Gel
Allen Loyd V Jr
Sep/Oct 2008
Pg. 454

Propafenone 1.5-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2008
Pg. 455

PostScription: The International Society of Pharmaceutical Compounding: A Discussion of Its Importance from the Perspective of ISPhC Leadership
Marro Diego
, Barbosa Carlos Mauricio
Sep/Oct 2008
Pg. 467

Prescription: Is "Globalization" a Good Idea?
Allen Loyd V Jr
Nov/Dec 2008
Pg. 474

Arthritis Epidemiology Impacts Pharmacists
Vance Dwight A
Nov/Dec 2008
Pg. 476-480

Compounding Challenges for Immunocompromised Patients
McElhiney Linda F
Nov/Dec 2008
Pg. 482-487

Case Reports: Compounding to Relieve Arthritis Pain
Marshall Robert
, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
Nov/Dec 2008
Pg. 498-504

Symbols: Historic and Current Uses
Bailey Emilee
Nov/Dec 2008
Pg. 505-507

Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers
Fyke Jeremy P
, Yale Robert N, Corbett Corinne, Litera Natalie
Nov/Dec 2008
Pg. 508-513

Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations
Trissel Lawrence A
Nov/Dec 2008
Pg. 524-528

Calculations
Stockton Shelly J
Nov/Dec 2008
Pg. 539

Glycerin, Sterile
Allen Loyd V Jr
Nov/Dec 2008
Pg. 542

Indomethacin 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 543

Ketorolac Tromethamine 2% Topical Gel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 544

Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream
Allen Loyd V Jr
Nov/Dec 2008
Pg. 546

Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism
Paoletti Jim
Nov/Dec 2008
Pg. 488-497

Insurance for the Compounding Pharmacy Business, Part 2: What, When, and Where
Baker Kenneth R
Nov/Dec 2008
Pg. 514-523

Branding: Give Your Small Business a Big Image
Storey Patricia L
Nov/Dec 2008
Pg. 537-538

Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 540

Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 541

Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules
Allen Loyd V Jr
Nov/Dec 2008
Pg. 545

Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules
Allen Loyd V Jr
Nov/Dec 2008
Pg. 547

Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules
Allen Loyd V Jr
Nov/Dec 2008
Pg. 548

Morphine Sulfate 20-mg and Prochlorperazine Maleate 10-mg Troches
Allen Loyd V Jr
Nov/Dec 2008
Pg. 549

Physical Compatibility and Chemical Stability of a Concentrated Solution of Atropine Sulfate (2 mg/mL) for Use as an Antidote in Nerve Agent Casualties
Donnelly Ronald F
, Corman Celine
Nov/Dec 2008
Pg. 550-552

Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration
Shields David E
, Aclan Jennifer, Szatkowski Aaron
Nov/Dec 2008
Pg. 553-557

PostScription: Supporting Compounding Around the World
Allen Loyd V Jr
Nov/Dec 2008
Pg. 565

Basics of Compounding: United States Pharmacopeia General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 10: First Revision: The Main Changes, Events, and Rationale
Okeke Claudia C
, Newton David W, Kastango Eric S, Allen Loyd V Jr
Nov/Dec 2008
Pg. 530-536

Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Vu Nicole T
, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
Nov/Dec 2008
Pg. 558-564

Return to Top